LncRNA‐HOTAIRM1 promotes aerobic glycolysis and proliferation in osteosarcoma via the miR ‐664b‐3p/Rheb/ mTOR pathway
Cancer Science · 2023
DOI: 10.1111/cas.15881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Xuecheng Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical…. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Changzhou Medical Center project, National Natural Science Foundation of China, Natural Science Foundation of Xinjiang Province.
Abstract (Originalsprache)
Osteosarcoma (OS), which is a common and aggressive primary bone malignancy, occurs mainly in children and adolescent. Long noncoding RNAs (lncRNAs) are reported to play a pivotal role in various cancers. Here, we found that the lncRNA HOTAIRM1 is upregulated in OS cells and tissues. A set of functional experiments suggested that HOTAIRM1 knockdown attenuated the proliferation and stimulated the apoptosis of OS cells. A subsequent mechanistic study revealed that HOTAIRM1 functions as a competing endogenous RNA to elevate ras homologue enriched in brain (Rheb) expression by sponging miR‐664b‐3p. Immediately afterward, upregulated Rheb facilitates proliferation and suppresses apoptosis by promoting the mTOR pathway‐mediated Warburg effect in OS. In summary, our findings demonstrated that HOTAIRM1 promotes the proliferation and suppresses the apoptosis of OS cells by enhancing the Warburg effect via the miR‐664b‐3p/Rheb/mTOR axis. Understanding the underlying mechanisms and targeting the HOTAIRM1/miR‐664b‐3p/Rheb/mTOR axis are essential for OS clinical treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, China.
- Dalian Medical University, Dalian, China.
- Changzhou No.6 People's Hospital, Nanjing Medical University, Changzhou, China.
- Changzhou Medical Center, Nanjing Medical University, Changzhou, China.
- Department of Orthopedics, Wuqia People's Hospital, Xinjiang, China.
ORCID-Profile: Dong Zhou, Yifei Shen
Förderung
- Changzhou Medical Center project
- National Natural Science Foundation of China
- Natural Science Foundation of Xinjiang Province
- Natural Science Foundation of Xinjiang Uygur Autonomous Region
Zitieren
APA
Yu, X., Duan, W., Wu, F., Yang, D., Wang, X., Wu, J., Zhou, D., & Shen, Y. (2023). LncRNA‐HOTAIRM1 promotes aerobic glycolysis and proliferation in osteosarcoma via the miR ‐664b‐3p/Rheb/ mTOR pathway. Cancer Science. https://doi.org/10.1111/cas.15881
Vancouver
Yu X, Duan W, Wu F, Yang D, Wang X, Wu J, et al. LncRNA‐HOTAIRM1 promotes aerobic glycolysis and proliferation in osteosarcoma via the miR ‐664b‐3p/Rheb/ mTOR pathway. Cancer Science. 2023. doi:10.1111/cas.15881
BibTeX
@article{Yu2023,
author = {Yu, Xuecheng and Duan, Weihao and Wu, Furen and Yang, Daibin and Wang, Xin and Wu, Jingbin and Zhou, Dong and Shen, Yifei},
title = {LncRNA‐HOTAIRM1 promotes aerobic glycolysis and proliferation in osteosarcoma via the miR ‐664b‐3p/Rheb/ mTOR pathway},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15881}
}
EUVIMED